Pharmsynthez Plans Ambitious NASDAQ Floatation

BMI View: Drugmakers based in developing countries will increase their presence in developed states. In the case of Pharmsynthez, this strategy will enable it to exploit the higher penetration of patented drugs in more advanced markets.

To read the full article, please choose one of the following options: